Zenodo
What is the evidence for bisphosphonate therapy in paediatric patients with calcinosis due to dermatomyositis?
By Tripdatabase.
Abstract
There is limited evidence suggesting that bisphosphonate therapy, particularly pamidronate, might benefit paediatric patients with calcinosis due to dermatomyositis, but further research is needed to confirm its efficacy and safety.
Keywords
- Inflammatory Myopathies and Dermatomyositis
- bisphosphonates
- pamidronate
- calcinosis
- dermatomyositis
- pediatric patients
- treatment efficacy